Mdivi-1 has been reported to inhibit DRP1 activation, preserve mitochondrial morphology, and reduce LPS-induced brain damage (Deng et al., 2018) and neuronal apoptosis in models of traumatic brain injury (Wu et al., 2016; Song et al., 2019). Here, DNM1L is linked to injury.